Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

156
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
156
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

233
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
233
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

343
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
343
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

219
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

182
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
182
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Anticholinergic burden and health‑related quality of life among adult patients in a resource‑limited setting: a cross‑sectional study.

International journal of clinical pharmacy·2026
Same author

From Dysbiosis to Diabetes: How Gut Microbiome Interventions Influence Type 2 Diabetes.

Current diabetes reviews·2026
Same author

The Effect of Polyphenol Supplementation in People with Multiple Sclerosis: A Systematic Review of Clinical Trials.

Nutrients·2026
Same author

Knowledge, Attitudes, Practices, Barriers, and Promotional Strategies Related to Clinical Data Interchange Standards Consortium Adoption Among Clinical Data Management Professionals: Semiqualitative Interview Study.

JMIR medical informatics·2026
Same author

Tick-Borne Encephalitis Vaccine Effectiveness and Impact in Slovenia, 2019-2024.

Pathogens (Basel, Switzerland)·2026
Same author

The Journey of Adult Patients with Lyme Disease in the United States: A Qualitative Interview Study and Patient-Reported, Health-Related Quality-of-Life Assessment.

Advances in therapy·2026
Same journal

Towards haplotypes of blood group genes: the impact of long-read sequencing in molecular immunohematology.

Annals of translational medicine·2026
Same journal

Development of pharmacological interventions for the treatment of sarcopenia.

Annals of translational medicine·2026
Same journal

Fertility preservation in young women with breast cancer: a narrative review of effectiveness, oncologic safety, and clinical practice implications.

Annals of translational medicine·2026
Same journal

Propofol-based total intravenous anesthesia and recurrence-free survival after hepatectomy-does it improve outcomes?

Annals of translational medicine·2026
Same journal

Is pulmonary hypertension still a contraindication for lung volume reduction?-a narrative review of contemporary evidence.

Annals of translational medicine·2026
Same journal

Calcium montmorillonite clay: a clinically oriented narrative review of emerging perioperative and supportive applications.

Annals of translational medicine·2026
See all related articles

Related Experiment Video

Updated: Dec 22, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.2K

Managing heart failure with preserved ejection fraction.

Alexander Davidson1, Nivashinie Raviendran1,2, Charisma Nair Murali1,2

  • 1Ageing Clinical and Experimental Research, University of Aberdeen, Scotland, UK.

Annals of Translational Medicine
|May 2, 2020
PubMed
Summary
This summary is machine-generated.

Heart failure with preserved ejection fraction (HFpEF) management requires individualized strategies due to limited mortality-reducing treatments. Research is advancing HFpEF pathophysiology understanding and exploring new therapeutic targets for better patient outcomes.

Keywords:
Heart failureheart failure with preserved ejection fraction (HFpEF)

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.9K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.9K

Related Experiment Videos

Last Updated: Dec 22, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.2K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.9K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.9K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathophysiology

Background:

  • Heart failure with preserved ejection fraction (HFpEF) prevalence is rising with an aging population.
  • Decompensated HFpEF frequently leads to prolonged hospital admissions, increasing morbidity and mortality.
  • Current understanding of HFpEF pathophysiology remains limited, hindering effective treatment development.

Purpose of the Study:

  • To review recent advances in understanding HFpEF pathophysiology.
  • To assess current and emerging treatment strategies for HFpEF.
  • To evaluate the impact of treatments on mortality, hospital admissions, and quality of life (QOL).

Main Methods:

  • Literature review of randomized controlled trials and current evidence.
  • Analysis of pathophysiological understanding and therapeutic targets.
  • Categorization of potential treatments by management strategy.

Main Results:

  • Understanding of HFpEF pathophysiology is improving, with a focus on identifying therapeutic targets.
  • Some evidence suggests ACE-inhibitors, angiotensin-neprilysin inhibitors, ARBs, and MRAs may benefit specific HFpEF patients (EF < 60%).
  • No universal treatment strategies are currently recommended for HFpEF.

Conclusions:

  • HFpEF management necessitates an individualized approach, considering patient comorbidities.
  • Further research is crucial to develop effective treatments that reduce morbidity and mortality in the broader HFpEF population.
  • Improving QOL remains a key treatment goal in HFpEF.